Rigel Pharmaceuticals (RIGL) Inventory (2018 - 2026)

Rigel Pharmaceuticals' Inventory history runs 9 years deep, the most recent figure standing at $11.7 million for Q1 2026.

• On a quarterly basis, Inventory rose 150.1% year-over-year to $11.7 million in Q1 2026; TTM through Mar 2026 was $11.7 million, a 150.1% increase from a year earlier, with the FY2025 full-year figure at $11.5 million, up 91.7% from the prior year.
• Inventory climbed to $11.7 million in Q1 2026 per RIGL's latest filing, from $11.5 million in the prior quarter.
• Across five years, Inventory topped out at $13.3 million in Q3 2025 and bottomed at $4.7 million in Q1 2025.
• The 5-year median for Inventory is $7.1 million (2022), against an average of $8.2 million.
• Across the five-year window, Inventory plunged 40.61% in 2024 and surged 178.07% in 2025, its largest moves.
• Year by year, Inventory stood at $9.1 million in 2022, then slumped by 39.44% to $5.5 million in 2023, then advanced by 8.69% to $6.0 million in 2024, then jumped by 91.7% to $11.5 million in 2025, then grew by 1.27% to $11.7 million in 2026.
• Per Business Quant, the three latest RIGL Inventory figures stand at $11.7 million (Q1 2026), $11.5 million (Q4 2025), and $13.3 million (Q3 2025).